Monod Bio

About

Monod Bio is a biotechnology company based in Seattle, WA, that specializes in AI-driven computational protein design. Founded in 2022 as a spin-out from the Baker Lab at the University of Washington Institute for Protein Design, the company focuses on developing advanced biosensors and diagnostic tools. Monod Bio leverages *de novo* protein engineering to create protein-based biosensors that emit light upon recognizing specific biomarkers, enhancing precision in research and clinical diagnostics. The company offers customizable Research-Use-Only (RUO) tools and clinical-grade In Vitro Diagnostics (IVDs) designed for accuracy and rapid deployment. Monod Bio's proprietary computational methods enable the design of novel proteins tailored for specific diagnostic or therapeutic applications. With a leadership team experienced in life sciences and diagnostics, Monod Bio is positioned to advance disease detection, biomarker analysis, and therapeutic development through its innovative technology.